Trailing-twelve-month (TTM) revenue is $7.74 Billion with a year-over-year growth of +20.04%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,659,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $1,872,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-03-31 | $1,986,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $2,222,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $7,739,000,000 |
Current P/S: $18,529,193,690 market capitalization ÷ $7,739,000,000 TTM revenue = 2.39x.
Market capitalization source: FMP quote. Quote observed 2026-09-22T19:59:59.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $2.22B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-22T23:55:29.115Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Ammonia | N/A | N/A | N/A | N/A | $1.7B | $2.2B |
| AN | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| All Regions Outside of US and Canada | N/A | N/A | N/A | N/A | N/A | $712M |
| CANADA | N/A | N/A |
$7.74B
$7.74 Billion
+20.04%
vs. $6.45B a year ago (TTM)
+11.04%
5 Year compound annual growth rate
1 Year
+20.04%
3 Year
+0.34%
5 Year
+11.04%
10 Year
+6.35%
15 Year
+2.78%
20 Year
+7.31%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $7.08B | +$1.15B | +19.34% |
| 2024 | $5.94B | ($695.00M) | (10.48%) |
| 2023 | $6.63B | ($4.55B) | (40.72%) |
| 2022 | $11.19B | +$4.65B | +71.09% |
| 2021 | $6.54B | +$2.41B | +58.54% |
| 2020 |
TTM Growth
+20.04%
3-Year CAGR
+0.34%
5-Year CAGR
+11.04%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-22T23:55:29.115Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| $419M |
| $421M |
| Non-US | $1.1B | $1.5B | $3.0B | $1.8B | N/A | N/A |
|---|
| UAN | N/A | N/A | N/A | N/A | $1.7B | $2.2B |
|---|
| UNITED STATES | $3.1B | $5.2B | $8.4B | $4.9B | N/A | N/A |
|---|
| Urea | N/A | N/A | N/A | N/A | $1.6B | $1.8B |
|---|
| N/A |
| N/A |
| N/A |
| $598M |
| Non-US | $1.1B | $1.5B | $3.0B | $1.8B | $1.5B | $1.7B |
|---|
| North America | N/A | N/A | N/A | N/A | N/A | $58M |
|---|
| United Kingdom [Domain] | N/A | N/A | N/A | N/A | N/A | $378M |
|---|
| UNITED STATES | $3.1B | $5.2B | $8.4B | $4.9B | $4.5B | $5.3B |
|---|
| $4.12B |
| ($466.00M) |
| (10.15%) |
| 2019 | $4.59B | +$161.00M | +3.64% |
| 2018 | $4.43B | +$299.00M | +7.24% |
| 2017 | $4.13B | +$445.00M | +12.08% |
| 2016 | $3.69B | ($623.30M) | (14.47%) |
